Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Opening Session Panel Discussion

Advertisement

Advertisement




Jun
16
Today In Oncology
Neoadjuvant Sacituzumab Govitecan in MIBC
Thyroid Cancer Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence
Two-Pronged Nudges Result in Timely Conversations Around Priorities of Cancer Care
MIBC Intravesical Recombinant BCG and Chemoimmunotherapy
Overall Survival Benefit With Ivonescimab Plus Chemotherapy in Advanced Squamous NSCLC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo